These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8744398)

  • 1. Rational design of an animal model for Alzheimer's disease: introduction of multiple human genomic transgenes to reproduce AD pathology in a rodent.
    Loring JF; Paszty C; Rose A; McIntosh TK; Murai H; Pierce JE; Schramm SR; Wymore K; Lee VM; Trojanowski JQ; Peterson KR
    Neurobiol Aging; 1996; 17(2):173-82. PubMed ID: 8744398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically.
    Agca C; Fritz JJ; Walker LC; Levey AI; Chan AW; Lah JJ; Agca Y
    BMC Neurosci; 2008 Feb; 9():28. PubMed ID: 18302776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential transgene expression patterns in Alzheimer mouse models revealed by novel human amyloid precursor protein-specific antibodies.
    Höfling C; Morawski M; Zeitschel U; Zanier ER; Moschke K; Serdaroglu A; Canneva F; von Hörsten S; De Simoni MG; Forloni G; Jäger C; Kremmer E; Roßner S; Lichtenthaler SF; Kuhn PH
    Aging Cell; 2016 Oct; 15(5):953-63. PubMed ID: 27470171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of transgenic mice expressing apolipoprotein E4(C112R) and apolipoprotein E4(L28P; C112R).
    Huber G; März W; Martin JR; Malherbe P; Richards JG; Sueoka N; Ohm T; Hoffmann MM
    Neuroscience; 2000; 101(1):211-8. PubMed ID: 11068149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
    Saul A; Wirths O
    Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity Accelerates Alzheimer-Related Pathology in
    Moser VA; Pike CJ
    eNeuro; 2017; 4(3):. PubMed ID: 28612048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
    Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX
    Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice.
    Ali SM; Siedlak SL; Gonzalez-DeWhitt PA; Altman RA; Glendening JM; Lowery DE; Savage MJ; Polites HG; Perry G; Greenberg BD
    Neurobiol Aging; 1996; 17(2):223-34. PubMed ID: 8744403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of beta-amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations.
    Malherbe P; Richards JG; Martin JR; Bluethmann H; Maggio J; Huber G
    Neurobiol Aging; 1996; 17(2):205-14. PubMed ID: 8744401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?
    Howlett DR; Richardson JC
    Histol Histopathol; 2009 Jan; 24(1):83-100. PubMed ID: 19012248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice.
    Chan ES; Chen C; Cole GM; Wong BS
    Sci Rep; 2015 Sep; 5():13842. PubMed ID: 26346625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner.
    Vincent B; Smith JD
    Eur J Neurosci; 2001 Jul; 14(2):256-66. PubMed ID: 11553277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
    Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury.
    Ezra Y; Oron L; Moskovich L; Roses AD; Beni SM; Shohami E; Michaelson DM
    Neuroscience; 2003; 121(2):315-25. PubMed ID: 14521991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background.
    Irizarry MC; Rebeck GW; Cheung B; Bales K; Paul SM; Holzman D; Hyman BT
    Ann N Y Acad Sci; 2000; 920():171-8. PubMed ID: 11193147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.